Showing results (11-20 of 54) with videos related to
Sort By:
Pageof 6
Neoplasia (New York, N.Y.)|September 27, 2015
Doxil synergizes with cancer immunotherapies to enhance antitumor responses in syngeneic mouse modelsJonathan Rios-Doria, Nicholas Durham, Leslie Wetzel, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|May 24, 2016
Lipid- and polyion complex-based micelles as agonist platforms for TNFR superfamily receptorsRyan N Gilbreth, Shabazz Novarra, Leslie Wetzel, et al.Cancer Biology & Therapy|March 24, 2009
Ectopic expression of histone H2AX mutants reveals a role for its post-translational modificationsJonathan Rios-Doria, Aneliya Velkova, Virna Dapic, et al.Current Pharmaceutical Design|July 16, 2009
The therapeutic potential of ADAM15Neali Lucas, Abdo J Najy, Mark L DayMethods in Molecular Biology (Clifton, N.J.)|March 6, 2003
Rescue and isolation of Rb-deficient prostate epithelium by tissue recombinationSimon W Hayward, Yuzhuo Wang, Mark L DayCellular Signalling|October 26, 2011
EGF promotes the shedding of soluble E-cadherin in an ADAM10-dependent manner in prostate epithelial cellsMagdalena M Grabowska, Brindar Sandhu, Mark L DayNeoplasia (New York, N.Y.)|April 2, 2005
pRb-Independent growth arrest and transcriptional regulation of E2F target genesMichael T McCabe, Odinaka J Azih, Mark L DayCancer Research|May 4, 2005
Regulation of DNA methyltransferase 1 by the pRb/E2F1 pathwayMichael T McCabe, Joanne N Davis, Mark L DayThe Journal of Biological Chemistry|April 25, 2008
The ectodomain shedding of E-cadherin by ADAM15 supports ErbB receptor activationAbdo J Najy, Kathleen C Day, Mark L DayCancer Research|February 19, 2008
ADAM15 supports prostate cancer metastasis by modulating tumor cell-endothelial cell interactionAbdo J Najy, Kathleen C Day, Mark L DayPageof 6